⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KVUE News
Kenvue Inc.
FDA Approves TYLENOL® with Naproxen, the First and Only Over-the-Counter Fixed-Dose Combination of Acetaminophen (650 mg) and Naproxen Sodium (220 mg)
prnewswire.com
KVUE
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026
businesswire.com
KVUE
Neutrogena® Announces 'Break the Rules,' a New Brand Mission Empowering Consumers to Break Beauty's Rules with Science
prnewswire.com
KVUE
Kenvue, Maker of Neutrogena(R), Aveeno(R), OGX(R), and Zyrtec(R), Beats 2025 Packaging Goal, Demonstrates Continued Progress With More Sustainable Innovation
accessnewswire.com
KVUE
Women Leaders Take Centre Stage at Procurement LIVE: The London Summit This September
globenewswire.com
V
KVUE
LISTERINE® Introduces Range of Mouthwash Intensities, Including New Extra Mild
prnewswire.com
KVUE
LACTAID® Invites Ice Cream Lovers to Ditch the Sunday Scaries with LACTAID® Sunday Dairies
prnewswire.com
KVUE
quantilope Launches 'quinn Search': The AI-Powered Knowledge Base Transforming Research Silos into an Instant Insights Vault
prnewswire.com
KVUE
PEP
Form 8-K
sec.gov
KVUE
MikeWorldWide Appoints Dave Aglar as Chief Integrated Media & Innovation Officer
prnewswire.com
GM
KVUE
IBM
VZ
NVS
PEP